Shares of Johnson Matthey PLC (LON:JMAT – Get Free Report) have been given an average rating of “Moderate Buy” by the six analysts that are presently covering the company, MarketBeat reports. One analyst has rated the stock with a sell rating, one has issued a hold rating, three have issued a buy rating and one has given a strong buy rating to the company. The average 12-month price objective among brokers that have issued a report on the stock in the last year is GBX 2,010 ($25.02).
Several research analysts recently weighed in on the stock. Berenberg Bank upped their price objective on shares of Johnson Matthey from GBX 1,650 ($20.54) to GBX 1,800 ($22.41) and gave the stock a “hold” rating in a research report on Monday, April 8th. Numis Securities reiterated a “buy” rating and set a GBX 2,200 ($27.39) price target on shares of Johnson Matthey in a research report on Wednesday, March 20th. Finally, Jefferies Financial Group restated a “buy” rating and issued a GBX 2,100 ($26.14) target price on shares of Johnson Matthey in a report on Wednesday, March 20th.
Read Our Latest Analysis on Johnson Matthey
Johnson Matthey Stock Up 2.0 %
Insider Activity at Johnson Matthey
In related news, insider Stephen Oxley purchased 18 shares of the business’s stock in a transaction that occurred on Wednesday, March 20th. The shares were acquired at an average price of GBX 1,864 ($23.20) per share, for a total transaction of £335.52 ($417.68). In other Johnson Matthey news, insider Stephen Oxley bought 18 shares of the company’s stock in a transaction dated Wednesday, March 20th. The shares were purchased at an average price of GBX 1,864 ($23.20) per share, for a total transaction of £335.52 ($417.68). Also, insider Liam Condon bought 24 shares of the company’s stock in a transaction dated Wednesday, April 17th. The shares were acquired at an average price of GBX 1,767 ($22.00) per share, for a total transaction of £424.08 ($527.92). Insiders have purchased a total of 66 shares of company stock worth $114,288 over the last quarter. Corporate insiders own 0.60% of the company’s stock.
About Johnson Matthey
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.
Read More
- Five stocks we like better than Johnson Matthey
- When to Sell a Stock for Profit or Loss
- MarketBeat Week in Review – 4/15 – 4/19
- 3 Fintech Stocks With Good 2021 Prospects
- Comprehensive Analysis of PayPal Stock
- What is a Special Dividend?
- Intuitive Surgical Stock Can Trend Much Higher This Year
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.